Papastavrou Jason D

Director · REFI, GXO

As of 2026-09-16, Papastavrou Jason D has 10 Form 4 transactions on record across 2 companies — 4 in the trailing 12 months.

Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.

Reconstructed holdings

Direct: $846KIndirect: $33K$879Kas of 2026-09-16
  • Direct $846K
  • Indirect $33K
REFIdirect55,870 sh$615K
GXOdirect5,012 sh$231K
REFIindirect3,000 sh$33K

Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.

Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.

Trades by company

REFI · 5 trades
2026-04-20: Award / grant, 6,324 sh ($0)2025-10-15: Purchase, 10,000 sh ($126K)2025-10-15: Purchase, 5,000 sh ($64K)2025-10-15: Purchase, 3,000 sh ($38K)2025-04-01: Award / grant, 5,071 sh ($0)
GXO · 5 trades
2025-05-13: Award / grant, 5,012 sh ($0)2025-05-13: Option exercise, 3,617 sh ($0)2025-05-13: Option exercise, 3,617 sh ($0)2025-01-02: Option exercise, 1,282 sh ($0)2025-01-02: Option exercise, 1,282 sh ($0)

Filing ledger

DateCompanyActionShares @ priceValueOwnership ΔOwned afterFiling
2025-10-15REFIPurchase10,000 @ $12.62$126K+25.3% of holding49,546Form 4
2025-10-15REFIPurchase5,000 @ $12.71$64Kownership Δ n/a5,000Form 4
2025-10-15REFIPurchase3,000 @ $12.68$38Kownership Δ n/a3,000Form 4
7 award / exercise / gift records — not counted as purchases
DateCompanyActionSharesOwned afterFiling
2026-04-20REFIAward / grant6,32455,870Form 4
2025-05-13GXOAward / grant5,0125,012Form 4
2025-05-13GXOOption exercise3,61762,697Form 4
2025-05-13GXOOption exercise3,6170Form 4
2025-04-01REFIAward / grant5,07139,546Form 4
2025-01-02GXOOption exercise1,2820Form 4
2025-01-02GXOOption exercise1,28259,080Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.